Additionally, in lung cancer, disruption of SIRT7-ARF signaling stabilizes ARF and thus attenuates cancer cell proliferation, providing a strategy to mitigate NSCLC progression (Kumari et al., 2024). The gene discussed is CDKN2A; the disease is non-small cell lung carcinoma.